Related Experiment Videos
Bifocal sclerosing osteosarcoma: unusual presentation and course
L Abramovici1, G C Steiner, Z Rosenberg
1Department of Pathology and Laboratory Medicine, Hospital for Joint Diseases, New York, NY 10009, USA.
Skeletal Radiology
|October 9, 1998
Summary
This case study highlights an exceptional long-term survival in a multifocal osteosarcoma patient with incomplete treatment. The sclerosing osteosarcoma showed unusual HMB-45 positivity, offering new insights into rare bone cancers.
Area of Science:
- Orthopedic Oncology
- Skeletal Radiology
- Tumor Biology
Background:
- Multifocal osteosarcoma, characterized by multiple primary tumor sites, is a rare and aggressive bone malignancy.
- Incomplete treatment of osteosarcoma typically correlates with poor prognosis and high risk of metastasis.
Observation:
- A 38-year-old woman presented with bifocal sclerosing osteosarcoma involving the left ilium and right proximal femur.
- The femoral lesion was surgically removed, while the iliac lesion remained untreated, and no chemotherapy was administered.
- The patient remained disease-free for 7 years post-initial treatment, despite incomplete management of the pelvic tumor.
Findings:
- The pelvic osteosarcoma demonstrated recent growth, leading to vascular compression and lower extremity edema.
- Elevated alkaline phosphatase levels were consistently observed throughout the patient's clinical course.
- Histopathological examination revealed HMB-45 positivity in the osteosarcoma, a finding not previously documented in this condition.
Implications:
- This case challenges conventional understanding of osteosarcoma treatment response and long-term survival.
- The HMB-45 positivity suggests potential alternative cellular origins or differentiation pathways in multifocal osteosarcoma.
- Further research into the pathogenesis of multifocal osteosarcoma, particularly HMB-45 positive variants, is warranted.